NCT01034852|Completed
Efficacy Study for Surgery After Previous Failed Catheter Ablation
SAVED
Surgery After Previous Failed Catheter Ablation
Loading search results
SAVED
Surgery After Previous Failed Catheter Ablation
Sponsor study identifier
observational
45
1 country
2
Study Start
May 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2011
Actual (reported)Study Completion
January 2011
Actual (reported)Specific Aims: The primary objective of this registry is to determine the percentage of patients who are free from atrial fibrillation (AF) at 6 and 12 months following a surgical ablation procedure when the patient has a history of failing one or more previous catheter based ablations for AF. The first 3 months following surgical ablation will be a blanking period; any arrhythmia occurring during this time will not be used to determine success. Primary Objectives:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2009
Date type not reportedThis date has not been verified as actual or estimated.
December 17, 2009
Actual (reported)December 18, 2009
Actual (reported)January 2011
Actual (reported)January 2011
Actual (reported)Determine the efficacy of surgical ablation for AF at 6, & 12 months both on and off of antiarrhythmic drugs following a failed catheter based ablation for AF.
1 year post operatively
Record and evaluate all complications associated with the surgical procedure.
1 year post operatively
Evaluate usage of anticoagulants at 6 and 12 months.
1 year post operatively
Determine the % of Pulmonary Veins that were electrically isolated by intra-operative, pre-surgical mapping.
1 year post operatively
Patients undergoing surgical ablation for Atrial Fibrillation that have failed one or more previous attempts at catheter ablation for Atrial Fibrillation
Epicardial pulmonary vein isolation with additional lesions as determined to be necessary by physician
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients that have undergone surgical ablation after failing catheter based ablation at investigator sites
Endovascular Research
Springfield, Oregon, 97477, United States
Cardiopulmonary Research Science and Technology Institute
Dallas, Texas, 75230, United States
no biospecimens will be obtained.
James R Edgerton, MD
Cardiopulmonary Research Science and Technology Institute
45 participants (actual enrollment reported by the registry).
First Submitted
December 17, 2009
First Posted
December 18, 2009
Study Start
May 2009
Date type not reportedThis date has not been verified as actual or estimated.
Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
Contact the study team to confirm eligibility.
Primary Completion
January 2011
Actual (reported)Study Completion
January 2011
Actual (reported)Last Updated
February 22, 2012
Record last verified: 2012-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: